Who owns DIANTHUS THERAPEUTICS INC?
- Ticker: DNTH
- CUSIP Number: 252828108
Tip: Access positions for across all investors
Analyze quarterly positions in Dianthus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Dianthus Therapeutics stock
Who bought or sold DIANTHUS THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
---|---|---|---|---|---|
FMR | 4.4M | $97M | 1% | Dec 2024 |
|
Avidity Partners Management | 2.9M | $63M | -2% | Dec 2024 |
|
Fairmount Funds Management | 2.7M | $59M | 0% | Dec 2024 |
|
Bain Capital Life Sciences Investors | 2.7M | $59M | -11% | Dec 2024 |
|
Octagon Capital Advisors | 2.1M | $46M | 21% | Dec 2024 |
|
RA Capital Management | 1.9M | $41M | -20% | Dec 2024 |
|
VR Adviser | 1.7M | $38M | 0% | Dec 2024 |
|
BlackRock | 1.7M | $36M | 0% | Dec 2024 |
|
TCG Crossover Management | 1.5M | $33M | 100% | Dec 2024 |
|
Vanguard Group | 1.3M | $28M | -2% | Dec 2024 |
|
Braidwell | 1.2M | $26M | 144% | Dec 2024 |
|
Alliancebernstein | 1.2M | $25M | 13% | Dec 2024 |
|
Henderson Group | 1.1M | $24M | 14% | Dec 2024 |
|
Vestal Point Capital | 1.1M | $23M | 172% | Dec 2024 |
|
5AM Venture Management | 1.0M | $22M | -17% | Dec 2024 |
|
State Street Corporation | 819k | $18M | 0% | Dec 2024 |
|
Rtw Investments | 667k | $15M | 0% | Dec 2024 |
|
Geode Capital Management | 486k | $11M | 0% | Dec 2024 |
|
Citadel Advisors | 423k | $9.2M | 604% | Dec 2024 |
|
Woodline Partners | 301k | $6.6M | 20% | Dec 2024 |
|
Dr. Jeffrey R. Jay, M.D. | 275k | $6.0M | 0% | Dec 2024 |
|
Tang Capital Management | 265k | $5.8M | 0% | Dec 2024 |
|
Northern Trust | 246k | $5.4M | 21% | Dec 2024 |
|
Alphabet | 209k | $4.5M | 0% | Dec 2024 |
|
Goldman Sachs Group | 208k | $4.5M | 158% | Dec 2024 |
|
Point72 Asset Management | 194k | $4.2M | -56% | Dec 2024 |
|
Adage Capital Partners GP | 180k | $3.9M | 100% | Dec 2024 |
|
Charles Schwab Investment Management | 167k | $3.6M | 1% | Dec 2024 |
|
Morgan Stanley | 116k | $2.5M | 72% | Dec 2024 |
|
Rhenman & Partners Asset Management AB | 114k | $2.5M | -24% | Dec 2024 |
|
Ally Bridge Group | 106k | $2.3M | 100% | Dec 2024 |
|
Millennium Management | 90k | $2.0M | 160% | Dec 2024 |
|
Walleye Trading Advisors | 83k | $1.8M | 176% | Dec 2024 |
|
Bank of America Corporation | 78k | $1.7M | -11% | Dec 2024 |
|
Bank of New York Mellon | 73k | $1.6M | 0% | Dec 2024 |
|
Nuveen Asset Management | 66k | $1.4M | 0% | Dec 2024 |
|
Wellington Management Company | 60k | $1.3M | 12% | Dec 2024 |
|
Cubist Systematic Strategies | 55k | $1.2M | 9% | Dec 2024 |
|
UBS Group | 54k | $1.2M | 89% | Dec 2024 |
|
American Century Companies | 44k | $959k | 4% | Dec 2024 |
|
Barclays | 43k | $933k | 3% | Dec 2024 |
|
Pnc Financial Services | 37k | $809k | 0% | Dec 2024 |
|
Rhumbline Advisers | 35k | $636k | -2% | Mar 2025 |
|
HighVista Strategies | 31k | $684k | 58% | Dec 2024 |
|
Citigroup | 31k | $666k | 76% | Dec 2024 |
|
Rafferty Asset Management | 29k | $620k | -7% | Dec 2024 |
|
ALPS Advisors | 24k | $522k | 7% | Dec 2024 |
|
Arrowpoint Asset Management | 21k | $453k | 0% | Dec 2024 |
|
Deutsche Bank Aktiengesellschaft | 20k | $436k | 56% | Dec 2024 |
|
ADAR1 Capital Management | 18k | $386k | -85% | Dec 2024 |
|
Susquehanna International | 17k | $360k | 100% | Dec 2024 |
|
Bessemer | 15k | $323k | 0% | Dec 2024 |
|
Mirae Asset Global Etfs Holdings | 15k | $316k | 2% | Dec 2024 |
|
Swiss National Bank | 14k | $314k | -17% | Dec 2024 |
|
MetLife Investment Advisors | 14k | $313k | 3% | Dec 2024 |
|
Point72 | 14k | $306k | 12% | Dec 2024 |
|
Wells Fargo & Company | 14k | $301k | -37% | Dec 2024 |
|
State of Wisconsin Investment Board | 13k | $284k | 50% | Dec 2024 |
|
Legal & General Group | 12k | $269k | 24% | Dec 2024 |
|
Jpmorgan Chase & Co | 12k | $264k | 14% | Dec 2024 |
|
Corebridge Financial | 12k | $259k | 100% | Dec 2024 |
|
Invesco | 12k | $251k | 7% | Dec 2024 |
|
Squarepoint Ops | 11k | $242k | -27% | Dec 2024 |
|
Two Sigma Investments | 11k | $231k | -5% | Dec 2024 |
|
Royal Bank of Canada | 10k | $219k | -65% | Dec 2024 |
|
New York State Common Retirement Fund | 9.7k | $211k | 0% | Dec 2024 |
|
T. Rowe Price Associates | 9.5k | $207k | 21% | Dec 2024 |
|
Intech Investment Management | 9.2k | $202k | 100% | Dec 2024 |
|
California State Teachers Retirement System | 8.1k | $176k | -14% | Dec 2024 |
|
SG Americas Securities | 7.1k | $129k | -26% | Mar 2025 |
|
Quest Partners | 4.2k | $92k | 273% | Dec 2024 |
|
Advisor Group Holdings | 3.1k | $85k | 0% | Dec 2024 |
|
Virtus ETF Advisers | 3.0k | $66k | -12% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 2.7k | $59k | 100% | Dec 2024 |
|
Summit Investment Advisors | 2.3k | $51k | 0% | Dec 2024 |
|
KBC Group NV | 1.6k | $35k | 100% | Dec 2024 |
|
Tower Research Capital | 1.4k | $30k | -41% | Dec 2024 |
|
Amalgamated Bank | 827.00 | $18k | 0% | Dec 2024 |
|
Sterling Capital Management | 711.00 | $16k | 812% | Dec 2024 |
|
Parkside Financial Bank & Trust | 385.00 | $8.4k | 0% | Dec 2024 |
|
Crowley Wealth Management | 221.00 | $4.0k | 0% | Mar 2025 |
|
GAMMA Investing | 214.00 | $3.9k | 73% | Mar 2025 |
|
Us Bancorp | 75.00 | $1.6k | 15% | Dec 2024 |
|
Rothschild Investment | 45.00 | $815.998500 | 350% | Mar 2025 |
|
SRS Capital Advisors | 32.00 | $698.000000 | 100% | Dec 2024 |
|
Lindbrook Capital | 21.00 | $457.999500 | 24% | Dec 2024 |
|
NISA Investment Advisors | 18.00 | $392.000400 | -75% | Dec 2024 |
|
CWM | 9.00 | $0 | 80% | Dec 2024 |
|
SBI Securities | 7.00 | $152.999700 | 100% | Dec 2024 |
|
Who sold out of Dianthus Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
---|---|---|---|
Atlas Venture Life Science Advisors | Sep 2024 | 77k | $2.1M |
Renaissance Technologies | Sep 2024 | 55k | $1.5M |
Marshall Wace | Sep 2024 | 54k | $1.5M |
Jane Street | Sep 2024 | 20k | $556k |
Rbf Capital | Sep 2024 | 11k | $295k |
Fred Alger Management | Sep 2024 | 9.6k | $264k |
Manufacturers Life Insurance Company | Sep 2024 | 8.9k | $243k |
Point72 Asia | Sep 2024 | 8.6k | $235k |
Ing Investment Management | Sep 2024 | 8.0k | $218k |
Qube Research & Technologies | Sep 2024 | 7.8k | $212k |
Steward Partners Investment Advisory | Sep 2024 | 3.1k | $86k |
TD Waterhouse Canada | Sep 2024 | 203.00 | $5.7k |